Horstmeier Paul
Known title: Chief Operating OfficerCIK: 0001780978
Associated companies
Transaction History
| HCAT | ▲ Buy | Option Exercise | 50,000 | $221K | 3/22/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 4,464 | $64K | 3/1/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 15,561 | $166K | 12/1/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 2,869 | $33K | 9/1/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 89 | $1K | 6/1/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 2,453 | $35K | 6/1/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 520 | $8K | 4/12/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 4,167 | $66K | 4/12/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,208 | $131K | 4/12/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 521 | $6K | 4/12/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 521 | $8K | 3/9/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 4,166 | $66K | 3/9/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 201 | $5K | 3/9/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 23,008 | $582K | 3/9/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 491 | $13K | 3/2/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 3,015 | $80K | 3/1/2022 | View on chart |
| HCAT | ▲ Buy | Grant | 3,164 | $0 | 3/1/2022 | View on chart |
| HCAT | ▲ Buy | Grant | 100,000 | $0 | 2/24/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 4,166 | $66K | 2/7/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 6,584 | $68K | 2/7/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 7,273 | $211K | 2/7/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 3,477 | $102K | 2/7/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 4,999 | $186K | 1/5/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 1,496 | $57K | 1/5/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 6,623 | $105K | 1/5/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 4,255 | $153K | 1/5/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 4,127 | $65K | 1/5/2022 | View on chart |
| HCAT | ▼ Sell | Open Market | 400 | $16K | 12/7/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,082 | $83K | 12/7/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 600 | $23K | 12/6/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,674 | $104K | 12/6/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,789 | $111K | 12/6/2021 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 9,261 | $388K | 12/2/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,001 | $105K | 11/5/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 8,127 | $420K | 11/5/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 10,750 | $170K | 11/5/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 622 | $33K | 11/5/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 9,750 | $468K | 10/5/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 1,000 | $49K | 10/5/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 10,750 | $170K | 10/5/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 6,063 | $96K | 9/7/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,535 | $139K | 9/7/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 6,063 | $333K | 9/7/2021 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 2,153 | $117K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks
Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.